The recent escalation in tariff impositions by the United States has once again thrown the much-anticipated trade agreement with India into a state of flux. Washington’s firm stance on introducing a 25% levy on certain Indian goods jeopardizes several sectors, including pharmaceuticals, textiles, and information technology services. Industry experts warn that these increased duties could lead to significant cost hikes for American consumers, threatening the competitive edge of Indian exports. Stakeholders are concerned that the stalemate might not only delay the finalization of the trade pact but could also reverse the progress made over the past…